K

Kite Pharma

Develops engineered T cell cancer therapies

Director – Scientific Communications

Technical WritingConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • At least 12 years of experience with a Bachelor of Science or Bachelor of Arts degree.
  • At least 10 years of experience with a Master of Science or Master of Arts degree.
  • At least 8 years of experience with a PhD or PharmD degree.

Responsibilities

  • Define, own, and proactively refresh an integrated publication strategy across assets, disease areas, and lifecycle stages, balancing launch, lifecycle-management, and pipeline priorities.
  • Own the scientific platform and ensure consistent, differentiated narratives across publications, congress disclosures, and related deliverables.
  • Integrate asset positioning, evidence assessment, external insights, and the evolving treatment landscape into publication strategy.
  • Identify evidence and communication gaps and partner with Medical Affairs, Clinical Development, Biostatistics, Strategy, and other functions to address them.
  • Lead portfolio strategy and sequencing for high-impact clinical, real-world, translational, and other scientific publications and data disclosures.
  • Determine the recommended congress, encore, and downstream externalization approach across the portfolio, anticipating scientific, operational, and compliance risks and dependencies.
  • Prioritize publication investment and vendor capacity across competing needs and make cross-asset trade-off recommendations when timing, positioning, budget, or resources conflict.
  • Decide which activities should be initiated, accelerated, combined, deferred, or discontinued within the approved strategy and budget, escalating only matters requiring governance approval.
  • Bring governance-ready recommendations that clearly explain the scientific rationale, options, implications, and risks.
  • Serve as the principal Publications adviser across Programme Teams, Global Brand Teams, evidence-generation forums, and senior governance bodies.
  • Lead complex cross-functional discussions, constructively challenge assumptions, and drive alignment and decisions without formal authority.
  • Own portfolio publication budget planning, resource allocation, vendor strategy, capacity planning, and performance oversight.
  • Ensure publication activities meet applicable scientific, authorship, ethical, legal, compliance, and company standards, including Good Publication Practice (GPP) and International Committee of Medical Journal Editors (ICMJE) principles.
  • Create inclusion by modeling inclusion and embedding the value of diversity in how teams are managed.
  • Develop talent by understanding employees’ skills, experience, aspirations, and potential and coaching them on current performance and future potential; ensure they receive feedback and insight to grow and develop.
  • Empower teams by aligning goals, purpose, and organizational objectives, holding teams accountable, removing barriers, and connecting teams to the broader organization.

Desired Qualifications

  • At least 8 years of scientific or medical publications experience in the biotechnology or pharmaceutical industry, including significant hematology/oncology and/or cell therapy experience.
  • Demonstrated ability to set publication priorities, resolve complex planning issues, and make sound recommendations with incomplete or evolving data.
  • Proven ability to lead cross-functional teams, influence senior stakeholders and external experts, facilitate discussion, and resolve differences without direct authority.
  • Strong working knowledge of Medical Affairs, Clinical Development, Legal, Intellectual Property, and other functions affected by Publications.
  • Strong commitment to publication ethics and knowledge of relevant guidelines, laws, industry standards, and corporate policies, including Good Publication Practice (GPP) and International Committee of Medical Journal Editors (ICMJE) principles.
  • Ability to travel up to 15%, including weekends.

About the Company

Kite Pharma

Develops engineered T cell cancer therapies

Kite Pharma develops cancer immunotherapies by engineering a patient’s own T cells to attack tumors. Its core product strategy centers on cell therapy where T cells are genetically modified to recognize cancer cells, expanded outside the body, and then infused back into the patient to destroy cancer. This approach differs from traditional drugs by using the immune system itself to fight cancer and by tailoring therapies to individual patients. Kite focuses on clinical trials and commercialization of approved therapies, often through partnerships and licensing with other pharmaceutical companies to reach patients worldwide. The company’s goal is to provide potentially lifesaving, durable cancer treatments and move toward a cure for cancer.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Santa Monica, CA
Founded
2009

Recently Posted Jobs

Explore more opportunities at Kite Pharma

See more jobs